Vascular-Targeted Therapies in Oncology provides an interesting insight to the current status and future potential of vascular-disrupting approaches in cancer management. Emphasis is placed on target development, preclinical assessment, and the use of such targeted approaches in combination with conventional treatment regimens and the current clinical status of these therapies.
About the Author
Dietmar W. Siemann is the editor of Vascular-Targeted Therapies in Oncology, published by Wiley.
